Cadrenal Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cadrenal Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q1 2023.
  • Cadrenal Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2023 was $3.53K, a 69.8% increase year-over-year.
  • Cadrenal Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2023 was $41.6K.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $41.6K $3.53K +$1.45K +69.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $40.2K $18.1K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $13.5K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.45K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.08K Jan 25, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.